首页 › 基金 › Paradigm Biocapital Advisors LP › MPLT
Paradigm Biocapital Advisors LP 对 MPLT 的持仓历史
MAPLIGHT THERAPEUTICS INC · 医疗保健
Paradigm Biocapital Advisors LP 在 Q2 2026 的 13F 申报中披露持有 MPLT(MAPLIGHT THERAPEUTICS INC)685,852 股,市值约 US$24.6M,约占其申报组合的 0.46%,在其申报持仓中市值排名第 24 位。 Paradigm Biocapital Advisors LP 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Paradigm Biocapital Advisors LP 对 MPLT 的持仓演变
Paradigm Biocapital Advisors LP 于 Q2 2026 首次披露 MPLT 持仓:685,852 股(约 US$24.6M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 685.85K | $24.58M | 新进 |
关于 MPLT 与 13F 数据
MPLT(MAPLIGHT THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 118 只申报持有 MPLT,申报仓位最大的包括:Novo Holdings A/S (US$132.1M), FCPM III SERVICES B.V. (US$115.6M), Nan Fung Group Holdings Ltd (US$34.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MPLT 的基金
- Novo Holdings A/S 3.69M 股 · $132.13M · Q2 2026
- FCPM III SERVICES B.V. 3.23M 股 · $115.63M · Q2 2026
- Nan Fung Group Holdings Ltd 971.25K 股 · $34.81M · Q2 2026
- 5AM Venture Management, LLC 950.01K 股 · $34.05M · Q2 2026
- Sanofi 912.04K 股 · $32.69M · Q2 2026
- Blue Owl Capital Holdings LP 729.93K 股 · $26.16M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 611.45K 股 · $21.91M · Q2 2026
- Velan Capital Investment Management LP 492.89K 股 · $17.67M · Q2 2026
- DAFNA Capital Management LLC 171.01K 股 · $6.13M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 125.43K 股 · $4.50M · Q2 2026
- STEMPOINT CAPITAL LP 106.91K 股 · $3.83M · Q2 2026
更多关于 Paradigm Biocapital Advisors LP
常见问题
How long has Paradigm Biocapital Advisors LP held MPLT?
Paradigm Biocapital Advisors LP has disclosed MPLT holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Paradigm Biocapital Advisors LP's current position in MPLT?
As of Q2 2026, Paradigm Biocapital Advisors LP holds 685.85K shares of MPLT (MAPLIGHT THERAPEUTICS INC), valued at $24.58M, representing 0.46% of its reported portfolio and ranking #24.
Has Paradigm Biocapital Advisors LP been buying or selling MPLT?
In the latest 13F filing (Q2 2026), Paradigm Biocapital Advisors LP newly opened its position in MPLT.
Which other funds hold MPLT?
Other major institutional holders of MPLT include Novo Holdings A/S, FCPM III SERVICES B.V., Nan Fung Group Holdings Ltd, among 118 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.